Company page
Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. is a public company traded under the ticker SUPN in the American market. The company has a market capitalization of approximately $2.58 billion. Supernus focuses on developing and commercializing products for the treatment of central nervous system diseases.
- Ticker
- SUPN:NASDAQ
- Asset type
- Stock
- Market cap
- $2.58B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD